Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brain Sciences is a clinical neuroscience company that specializes in the development of advanced digital tools for assessing brain health and cognitive function. Founded by renowned neuropsychologist Dr. Elkhonon Goldberg, the company provides a comprehensive suite of validated cognitive tests designed for use in clinical practice, research, and corporate wellness. Its flagship product, the Brain Health Assessment (BHA), offers a rapid and objective measure of various cognitive domains, including memory, executive function, and attention. By leveraging digital technology, Brain Sciences aims to make high-quality neuropsychological evaluation more accessible and efficient for healthcare providers and patients alike. The company's solutions are utilized to monitor cognitive decline, evaluate the impact of treatments, and support the early detection of neurological conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brain Sciences.